# Growth Hormone Axis Peptide FAQ — CJC-1295/Ipamorelin, MOTS-c, Sermorelin — Aus Peptide

> Frequently asked questions about CJC-1295/Ipamorelin, MOTS-c, and sermorelin — Growth Hormone Axis research peptides — answered from the peer-reviewed literature, with citations.

Direct, citation-anchored answers to the questions readers most often bring to CJC-1295/Ipamorelin, MOTS-c, and sermorelin.

## What is CJC-1295 / Ipamorelin good for?

CJC-1295/Ipamorelin is researched as a way to raise the body's own growth hormone (GH) output by activating two different pituitary receptors at once — the GHRH receptor via CJC-1295, and the ghrelin receptor via ipamorelin. In research-use communities, people most often discuss it in the context of sleep quality, workout recovery, and gradual changes in body composition, and cell-based studies show the two receptors reinforce each other's signal [5]. No published human trial has tested the fixed combination itself, so what it is 'good for' in people remains inferred rather than measured directly.

## What are the bad side effects of CJC-1295 and Ipamorelin?

Community reports describe injection-site redness or swelling as the most common complaint, along with occasional water retention, facial flushing right after dosing, tingling in the hands, grogginess, or lightheadedness. At a mechanistic level, growth hormone secretagogues as a class are associated with reduced insulin sensitivity and higher blood glucose [2], and the elevated IGF-1 that results from raising GH is a theoretical concern for anyone with an active or recent malignancy [3]. None of this is a complete safety profile, since the combination has never been tested in a controlled clinical trial.

## How long do CJC-1295 and Ipamorelin take to work?

Community accounts describe some effects, like better sleep, appearing within one to two weeks, with recovery and body-composition changes typically described as building gradually over five or more weeks. Pharmacologically, CJC-1295 with the DAC modification is known to elevate GH for six or more days and IGF-1 for nine to eleven days after a single dose [3], while ipamorelin produces a much shorter, same-day pulse — so the two components act on very different timeframes, which this site reports rather than resolves into a single answer.

## How many mg of CJC-1295 and Ipamorelin should I take?

This site does not recommend a dose of CJC-1295, ipamorelin, or any peptide for any person — that determination belongs to a licensed clinician, and the fixed combination has never been formally studied to establish one. The literature is limited to single-agent research doses used in unrelated trials, not a validated protocol for the combined product; treating any online-quoted milligram figure as medical guidance would be a misreading of the evidence.

## What does the MOTS-c peptide do?

MOTS-c is a small peptide encoded inside mitochondrial DNA that helps cells sense and respond to metabolic stress. Its clearest documented actions are activating AMPK, a cellular energy switch that improves glucose handling [10], and directly binding casein kinase 2 (CK2), which appears to boost muscle glucose uptake while helping prevent muscle-tissue loss in animal studies [6]. It does not act on the pituitary gland or the growth-hormone-releasing pathways that the other two peptides on this desk use.

## What are the negative side effects of MOTS-c?

No controlled human trial has tested MOTS-c for safety, so there is no established side-effect profile to report, and this site will not invent one. What the literature does establish are gaps: no human efficacy trials exist, no validated human dosing has been published, and MOTS-c is sold only as an unregulated research chemical, meaning identity and purity are not independently verified [7][8].

## Is MOTS-c legal to buy?

MOTS-c is not approved by the FDA for any human use and is sold only as a research chemical, not for human consumption. It is also treated as a prohibited substance in elite sport by anti-doping authorities. This site does not address where to obtain any peptide; readers should treat unregulated-market sourcing as a separate question from the compound's research legality.

## How often do you inject MOTS-c?

There is no published human dosing schedule for MOTS-c, and this site does not recommend an injection frequency for any peptide. The animal studies behind most MOTS-c findings used repeated dosing over periods of weeks, but rodent protocols do not translate into a validated human schedule [9].

## What is sermorelin?

Sermorelin is a synthetic 29-amino-acid peptide that mimics the first 29 amino acids of the body's own growth hormone-releasing hormone (GHRH) — the shortest fragment known to keep full activity at the GHRH receptor. It was previously FDA-approved under a discontinued brand for a narrow pediatric growth-deficiency indication and is now most often obtained through compounding pharmacies [11].

## What does sermorelin do to the body?

Sermorelin binds the GHRH receptor on the pituitary gland, prompting it to synthesize and release more of the body's own growth hormone in its normal pulsing pattern, which in turn raises IGF-1 [11]. In a trial of healthy older men, twice-daily dosing over 14 days raised 24-hour GH and IGF-1 to levels indistinguishable from those of young men, without changing fasting blood sugar [17].

## Does sermorelin work?

In the specific, narrow use it was originally approved for — accelerating growth in children with confirmed growth hormone deficiency — sermorelin has clear trial evidence: once-daily dosing raised first-year height velocity from about 4.1 cm/year to roughly 7-8 cm/year [15]. For the broader anti-aging and wellness claims it's now marketed for in adults, the evidence is thinner, and a widely cited 2008 editorial concluded that using GH secretagogues this way was "not yet ready for prime time" [13].

## How long does it take for sermorelin to work?

In controlled trials, measurable hormonal changes have appeared within the study window rather than instantly: a two-week trial in older men showed dose-related GH/IGF-1 increases by day 14 [17], and a pediatric growth trial measured its accelerating effect on height velocity over a full first year of daily dosing [15]. Community reports describe subjective effects like better sleep appearing within one to two weeks, with more noticeable changes described as building over two to three months.

---

Aus Peptide is an independent reading room for growth-hormone-axis literature — not a clinic, not a supplier, and not a substitute for a conversation with a licensed physician.